Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
8.33
+0.26 (3.22%)
At close: Aug 8, 2025, 4:00 PM
8.30
-0.03 (-0.42%)
After-hours: Aug 8, 2025, 4:36 PM EDT
Fennec Pharmaceuticals Market Cap
Fennec Pharmaceuticals has a market cap or net worth of $230.06 million as of August 8, 2025. Its market cap has increased by 28.17% in one year.
Market Cap
230.06M
Enterprise Value
226.74M
1-Year Change
28.17%
Ranking
Category
Stock Price
$8.33
Market Cap Chart
Since December 31, 2004, Fennec Pharmaceuticals's market cap has increased from $65.80M to $230.06M, an increase of 249.64%. That is a compound annual growth rate of 6.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 230.10M | 32.70% |
Dec 31, 2024 | 173.40M | -41.97% |
Dec 29, 2023 | 298.80M | 18.62% |
Dec 30, 2022 | 251.90M | 120.19% |
Dec 31, 2021 | 114.40M | -40.51% |
Dec 31, 2020 | 192.30M | 48.95% |
Dec 31, 2019 | 129.10M | 2.54% |
Dec 31, 2018 | 125.90M | -20.82% |
Dec 29, 2017 | 159.00M | 444.52% |
Dec 30, 2016 | 29.20M | 53.68% |
Dec 31, 2015 | 19.00M | -28.30% |
Dec 31, 2014 | 26.50M | 208.14% |
Dec 31, 2013 | 8.60M | -34.35% |
Dec 31, 2012 | 13.10M | 61.73% |
Dec 30, 2011 | 8.10M | -55.98% |
Dec 31, 2010 | 18.40M | 260.78% |
Dec 31, 2009 | 5.10M | - |
Dec 31, 2008 | 5.10M | -85.26% |
Dec 31, 2007 | 34.60M | 138.62% |
Dec 29, 2006 | 14.50M | -51.67% |
Dec 30, 2005 | 30.00M | -54.41% |
Dec 31, 2004 | 65.80M | - |
Dec 31, 2004 | 65.80M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 575.32B |
Johnson & Johnson | 413.10B |
AbbVie | 351.30B |
Abbott Laboratories | 229.85B |
AstraZeneca | 227.78B |
Novartis AG | 223.01B |
UnitedHealth Group | 221.95B |
Novo Nordisk | 213.92B |